Jin Xu

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial

Véronique Dièras, David Miles, Sunil Verma et al. · The Lancet Oncology · 2017 · 656 citations

Medicine, Oncology, Pharmacology +17

Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

Sara A. Hurvitz, Miguel Martín, W. Fraser Symmans et al. · The Lancet Oncology · 2017 · 529 citations · Full text

Medicine, Oncology, Pharmacology +17

Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer

Derek S. Welsbie, Jin Xu, Yu Chen et al. · Cancer Research · 2009 · 181 citations · Full text

Medicine, Molecular Biology, Oncology +17

Mechanistic studies on the chiral recognition of polysaccharide-based chiral stationary phases using liquid chromatography and vibrational circular dichroism

Shengli Ma, Shun-Qing Shen, H. Lee et al. · Journal of Chromatography A · 2009 · 107 citations

Pharmacy, Biochemistry, Carbohydrate Chemistry +16

Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study

Christophe Schmitt, Joanne I. Adamkewicz, Jin Xu et al. · Thrombosis and Haemostasis · 2020 · 96 citations · Full text

Medicine, Hematology, Pharmacology +15